View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
July 1, 2020

Significant clinical unmet needs remain in idiopathic pulmonary fibrosis

By Victoria Smith

Idiopathic pulmonary fibrosis (IPF) remains an area of high unmet clinical need. GlobalData has identified four key unmet needs in this disease space, including increased earlier diagnosis, improved drug safety and efficacy, improvement in patient quality of life, and treatments for patients with severe disease.

Key opinion leaders interviewed by GlobalData noted that it is challenging to definitively diagnose IPF early in the clinical course of the disease. Read more here.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU